SpaceX bought 1,279 Cybertrucks in Q4 2025, representing over 18% of Tesla’s total US sales during the quarter. That’s not fleet expansion—that’s a bailout wearing corporate camouflage. When your biggest customer shares the same CEO, the sales numbers start looking less like market validation and more like financial theater.
The Numbers Tell a Brutal Story
Total US Cybertruck sales plummeted 48% in 2025 to just 20,300 units.
Tesla moved barely 20,300 Cybertrucks in America last year, a 48% nosedive from 2024 that makes the vehicle’s polarizing design seem quaint compared to its market rejection. Elon Musk’s 2019 forecast of 250,000 annual production looks like pure fantasy now—Tesla hit roughly 8% of that target.
Q1 2026 brought more pain with deliveries crashing to 3,519 units, down 45% year-over-year. These aren’t growing pains; they’re death throes.
Family Business or Market Manipulation?
SpaceX’s bulk purchases raise questions about Tesla’s reported sales transparency.
SpaceX justified the purchases as “fleet replacements” for operations at facilities like Starbase, Texas. Fair enough—rocket companies need truck. But when related entities controlled by the same person buy nearly one-fifth of your struggling product’s output, you’re not measuring consumer demand anymore. You’re watching corporate accounting gymnastics.
S&P Global Mobility data shows SpaceX and other Musk ventures combined for roughly 19% of Q4 registrations, turning what should be market metrics into family transactions.
What This Means for Your Investment Decisions
Tesla’s credibility on future product launches now carries an asterisk.
This Cybertruck situation creates a troubling precedent for evaluating Tesla’s next moves. When a company props up disappointing sales through internal purchases, how do you trust the numbers on future products? Tesla investors deserve transparency about which sales represent genuine market adoption versus corporate reshuffling.
EV buyers considering Tesla alternatives now have concrete evidence that even Musk’s most hyped products can face brutal market reality—regardless of what the initial sales figures suggest.
